Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Join SI Premium – FREE
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q3 EPS of ($0.44), $0.08 worse than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- RBC Capital Starts Tabcorp Holdings (TAH:AU) (TABCF) at Outperform
- LEEF Brands appoints Hirsh Jain to board as independent director
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
